Skip to content

Nipro Diabetes Systems, Inc.

United StatesFDA applicant, unverified

Devices
5
FDA recalls
1

At a glance

Counted by deviCERTS from registry records

Market reach

United States
FDA recalls

What Nipro Diabetes Systems, Inc. makes

Nipro Diabetes Systems, Inc. manufactures insulin delivery devices, including pre-filled insulin syringes (GLUCOPRO SYRINGE), disposable infusion sets (GLUCOPRO INFUSION SET and GLUCOPRO EVO INFUSION SET SERIES), and insulin pumps (AMIGO INSULIN PUMP and GLUCOPRO EVO INFUSION PUMP). These products are designed for subcutaneous insulin administration in diabetes management.

The company’s devices are classified as Class II under FDA regulations and are authorised via the 510(k) pathway. The portfolio is listed in the FDA’s 510(k) database. The manufacturer is based in the United States.

AI-generated from registry data, 26 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue5

Newest first, rows 1-5 of 5

FDA recalls1

Recalls are matched to the firm by name. FDA recall data as of 1 Nov 2026.

FDA recall records list 1 recall initiated by Nipro Diabetes Systems, Inc., initiated on 2004-05-07. By recorded status: 1 terminated. The reasons filed fall into these groups: other reasons as filed. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.

Generated automatically from FDA recall records, as a summary of the records listed below. It describes what the records state and is not an assessment of this manufacturer.

  • 2004

    • 7 May 2004 Z-1335-04 Unclassified (pre-2012) Terminated A FDA inspection of the firm revealed deficiencies in the company's quality system. Problems exhibited may include motor failure or unintended operation. Distribution: Distributed to New York, New Jersey, Florida,Indiana, Utah, Colorado and Wyoming. Submission number: K013309

Frequently asked questions

How many devices does Nipro Diabetes Systems, Inc. have in the registry?

The registry currently lists 5 devices for Nipro Diabetes Systems, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Nipro Diabetes Systems, Inc.'s devices?

Among its 5 most recently registered devices, Nipro Diabetes Systems, Inc. has devices listed in FDA 510(k) (5 devices).

What risk classes do Nipro Diabetes Systems, Inc.'s devices fall under?

Among its 5 most recently registered devices, the classes recorded for Nipro Diabetes Systems, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

Are there FDA recall records for Nipro Diabetes Systems, Inc.?

FDA recall records list 1 recall initiated by Nipro Diabetes Systems, Inc., the most recent initiated on 7 May 2004. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What are the newest devices from Nipro Diabetes Systems, Inc. in the registry?

The most recently registered devices listed for Nipro Diabetes Systems, Inc. include GLUCOPRO SYRINGE, MODEL GPSY-XXXXXXXX, GLUCOPRO INFUSION SET, MODEL GPISXXXXXXXX SERIES, AMIGO INSULIN PUMP and GLUCOPRO EVO INFUSION PUMP.

Generated automatically from registry data and not verified by a human reviewer.